The role of qualitative and quantitative MRI assessment of multiple sclerosis lesions according to their in evaluating the efficacy of intravenous immunoglobulin G

Neuroradiology

Volumn 46, Issue 4, 2004, Pages 287-290

  Koçer, Belgin ^a,b   Yildirim Gurel S ^b   Tali, E T ^b   Irkec C ^b   Isik S ^b  

^a Gazi University Faculty of Medicine ^*  (Turkey)

^b GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Expanded disability status scale; Immunoglobulin G; Magnetic resonance imaging; Multiple sclerosis

Indexed keywords

IMMUNOGLOBULIN G; PLACEBO;

ADULT; ARTHRALGIA; ARTICLE; BRAIN DISEASE; BRAIN STEM; CEREBELLUM; CEREBELLUM DISEASE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISABILITY; DISEASE CLASSIFICATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FEVER; HUMAN; HYPOTENSION; IMMUNOTHERAPY; LABORATORY TEST; MALAISE; MALE; MULTIPLE SCLEROSIS; MYALGIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RATING SCALE; SCORING SYSTEM; STATISTICAL ANALYSIS; VOLUMETRY;

ADULT; BRAIN STEM; CEREBELLUM; CEREBRAL CORTEX; DISABLED PERSONS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PLACEBOS; RECURRENCE; TREATMENT OUTCOME;

EID: 2342650116     PISSN: 00283940     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00234-003-1088-8     Document Type: Article

References (18)

1. Isaac C, Li DK, Genton M, Jardine C, et al (1988) Multiple sclerosis: a serial study using MRI in relapsing patients. Neurology 38: 1511-1515
2. Kappos L, Stadt D, Rohrbach E, et al (1988) Gadolinium-DTPA-enhanced magnetic resonance imaging in the evaluation of different disease courses and disease activity in multiple sclerosis. Neurology 38 [Suppl.]: 255
3. Willoughby EW, Grochowsky E, Li DKB, Oger J, Kastrukoff LF, Paty DW (1989) Serial magnetic resonance scanning in multiple sclerosis: a second prospective study in relapsing patients. Ann Neurol 25: 43-49
4. Zhao GJ, Li DK, Wolinsky JS, et al (1997) Clinical and magnetic resonance imaging changes correlate in a clinical trial monitoring cyclosporine therapy for multiple sclerosis. J Neuroimaging 7: 1-7
5. Edan G, Miller D, Clanet M, et al (1997) Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomized multicentre study of active disease using MRI and clinical criteria. J Neurol Neurosurg Psychiatry 62: 112-118
6. Achiron A, Pras E, Gilad R, et al (1992) Open controlled therapeutic trial of intravenous immune globulin in relapsing-remitting multiple sclerosis. Arch Neurol 49: 1233-1236
7. Hahn AF, Bolton CF, Zochodne D, Feasby TE (1995) Intravenous Immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy (CIDP): a double-blind, placebo-controlled, crossover study. Brain 119: 1067-1078
8. Huber SJ, Paulson GW, Chakeres D, et al (1988) Magnetic resonance imaging and clinical correlations in multiple sclerosis. J Neurol Sci 86: 1-12
9. Poser CM, Paty DW, Scheinberg L, et al (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13: 227-231
10. Grimaud J, Lai M, Thorpe J, et al (1996) Quantification of MRI lesion load in multiple sclerosis: a comparison of three computer-assisted techniques. Magn Reson Imaging 14: 495-505
11. Rovaris M, Filippi M, Calori G, et al (1997) Intra-observer reproducibility in measuring new putative MR markers of demyelination and axonal in multiple sclerosis: a comparison with conventional T2-weighted images. J Neurol 244: 266-270
12. Hedier I (1992) White matter disease in the elderly. Neuroimaging Clin North Am 2: 441-450
13. Achiron A, Barak Y, Goren M, et al (1996) Intravenous immune globulin in multiple sclerosis: clinical and neuroradiological results and implications for possible mechanisms of actions. Exp Immunol 104 [Suppl 1]: 67-70
14. Sorensen PS, Wanscher B, Jensen CV, et al (1998) Intravenous immunoglobuline G reduces MRI activity in relapsing multiple sclerosis. Neurology 50: 1273-1281
15. Molyneux PD, Fillipi M, Barkhof F, et al (1998) Correlations between monthly enhanced MRI lesion rate and changes in T2 lesion volume in multiple sclerosis. Ann Neurol 43: 332-339
16. van Walderveen MA, Lycklama à Nijeholt GJ, Ader HJ (2001) Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging: relation to clinical characteristics in subgroups of patients with multiple sclerosis. Arch Neurol 58: 76-81
17. Fillipi M, Paty DW, Kappos L, et al (1995) Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: a follow-up study. Neurology 45: 225-260
18. Khoury SJ, Guttmann CRG, Orav EJ, et al (1994) Longitudinal MRI in multiple sclerosis: correlation between disability and lesion burden. Neurology 44: 2120-2124